HEADER CELL ADHESION 12-APR-19 6RD2 TITLE ENAH EVH1 IN COMPLEX WITH AC-[2-CL-F]-[PROM-2]-[PROM-1]-TEDEL-NH2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN ENABLED HOMOLOG; COMPND 3 CHAIN: B, A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: R84A IS MUTATED FOR MODELLING AS ONLY THE BACKBONE WAS COMPND 6 VISIBLE; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: THR-GLU-ASP-GLU-NLW; COMPND 9 CHAIN: C, D; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ENAH, MENA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PGEX-4T-1; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 12 ORGANISM_TAXID: 32630 KEYWDS PROLINE-RICH MOTIF, ACTA, ENA/VASP INHIBITOR, ACTIN, PROTEIN-PROTEIN KEYWDS 2 INTERACTION, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR M.BARONE,Y.ROSKE REVDAT 7 31-JAN-24 6RD2 1 REMARK REVDAT 6 26-OCT-22 6RD2 1 JRNL LINK REVDAT 5 17-FEB-21 6RD2 1 JRNL REVDAT 4 10-FEB-21 6RD2 1 JRNL REVDAT 3 02-DEC-20 6RD2 1 JRNL REVDAT 2 25-NOV-20 6RD2 1 JRNL REVDAT 1 13-MAY-20 6RD2 0 JRNL AUTH M.BARONE,M.MULLER,S.CHIHA,J.REN,D.ALBAT,A.SOICKE,S.DOHMEN, JRNL AUTH 2 M.KLEIN,J.BRUNS,M.VAN DINTHER,R.OPITZ,P.LINDEMANN, JRNL AUTH 3 M.BEERBAUM,K.MOTZNY,Y.ROSKE,P.SCHMIEDER,R.VOLKMER,M.NAZARE, JRNL AUTH 4 U.HEINEMANN,H.OSCHKINAT,P.TEN DIJKE,H.G.SCHMALZ,R.KUHNE JRNL TITL DESIGNED NANOMOLAR SMALL-MOLECULE INHIBITORS OF ENA/VASP JRNL TITL 2 EVH1 INTERACTION IMPAIR INVASION AND EXTRAVASATION OF BREAST JRNL TITL 3 CANCER CELLS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 117 29684 2020 JRNL REFN ESSN 1091-6490 JRNL PMID 33184177 JRNL DOI 10.1073/PNAS.2007213117 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.OPITZ,M.MUELLER,C.REUTER,M.BARONE,A.SOICKE,Y.ROSKE, REMARK 1 AUTH 2 K.PIOTUKH,P.HUY,M.BEERBAUM,B.WIESNER,M.BEYERMANN, REMARK 1 AUTH 3 P.SCHMIEDER,C.FREUND,R.VOLKMER,H.OSCHKINAT,H.G.SCHMALZ, REMARK 1 AUTH 4 R.KUEHNE REMARK 1 TITL A MODULAR TOOLKIT TO INHIBIT PROLINE-RICH MOTIF-MEDIATED REMARK 1 TITL 2 PROTEIN-PROTEIN INTERACTIONS. REMARK 1 REF PROC. NATL. ACAD. SCI. V. 112 5011 2015 REMARK 1 REF 2 U.S.A. REMARK 1 REFN ESSN 1091-6490 REMARK 1 PMID 25848013 REMARK 1 DOI 10.1073/PNAS.1422054112 REMARK 2 REMARK 2 RESOLUTION. 1.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3260: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.11 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 116220 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5812 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.1429 - 3.1066 1.00 3871 204 0.1796 0.1869 REMARK 3 2 3.1066 - 2.4659 1.00 3816 201 0.1742 0.1995 REMARK 3 3 2.4659 - 2.1542 1.00 3765 198 0.1676 0.1937 REMARK 3 4 2.1542 - 1.9572 1.00 3796 199 0.1536 0.1576 REMARK 3 5 1.9572 - 1.8170 1.00 3759 198 0.1637 0.2093 REMARK 3 6 1.8170 - 1.7098 1.00 3765 198 0.1587 0.1950 REMARK 3 7 1.7098 - 1.6242 1.00 3757 198 0.1537 0.1823 REMARK 3 8 1.6242 - 1.5535 1.00 3736 197 0.1546 0.1952 REMARK 3 9 1.5535 - 1.4937 1.00 3771 197 0.1620 0.2287 REMARK 3 10 1.4937 - 1.4421 1.00 3741 197 0.1770 0.2466 REMARK 3 11 1.4421 - 1.3970 1.00 3732 197 0.1886 0.2330 REMARK 3 12 1.3970 - 1.3571 1.00 3757 197 0.1980 0.2570 REMARK 3 13 1.3571 - 1.3214 1.00 3764 197 0.2081 0.2514 REMARK 3 14 1.3214 - 1.2891 1.00 3693 195 0.2233 0.2781 REMARK 3 15 1.2891 - 1.2598 1.00 3758 198 0.2411 0.2873 REMARK 3 16 1.2598 - 1.2330 1.00 3745 197 0.2658 0.3444 REMARK 3 17 1.2330 - 1.2083 1.00 3738 197 0.2750 0.3204 REMARK 3 18 1.2083 - 1.1855 1.00 3717 195 0.2856 0.3384 REMARK 3 19 1.1855 - 1.1644 1.00 3716 195 0.3079 0.3055 REMARK 3 20 1.1644 - 1.1446 1.00 3753 198 0.3255 0.3651 REMARK 3 21 1.1446 - 1.1262 1.00 3709 195 0.3426 0.3622 REMARK 3 22 1.1262 - 1.1088 1.00 3759 198 0.3666 0.3855 REMARK 3 23 1.1088 - 1.0925 1.00 3717 196 0.3939 0.4288 REMARK 3 24 1.0925 - 1.0771 1.00 3737 197 0.4624 0.4504 REMARK 3 25 1.0771 - 1.0626 1.00 3726 196 0.5157 0.5285 REMARK 3 26 1.0626 - 1.0488 1.00 3742 197 0.5174 0.5381 REMARK 3 27 1.0488 - 1.0357 0.99 3722 196 0.5292 0.5190 REMARK 3 28 1.0357 - 1.0232 0.90 3300 173 0.5252 0.6018 REMARK 3 29 1.0232 - 1.0113 0.91 3456 183 0.5383 0.5726 REMARK 3 30 1.0113 - 0.9999 0.65 2390 128 0.5628 0.6048 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.016 2154 REMARK 3 ANGLE : 1.580 2935 REMARK 3 CHIRALITY : 0.111 304 REMARK 3 PLANARITY : 0.011 397 REMARK 3 DIHEDRAL : 11.931 1730 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6RD2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-APR-19. REMARK 100 THE DEPOSITION ID IS D_1292101798. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 118323 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.000 REMARK 200 RESOLUTION RANGE LOW (A) : 42.106 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 14.60 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 13.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5ND0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.41M AMMONIUM SULFATE, 1000MM REMARK 280 AMMONIUM NITRATE, PH 7.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 300.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 74.19500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 74.19500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 84 CG CD NE CZ NH1 NH2 REMARK 470 SER A 2 OG REMARK 470 LYS A 69 CG CD CE NZ REMARK 470 ARG A 84 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 3 O HOH A 302 1.98 REMARK 500 O SER A 2 O HOH A 303 2.08 REMARK 500 O HOH A 336 O HOH A 391 2.11 REMARK 500 O1 NO3 A 202 O HOH A 304 2.13 REMARK 500 O HOH B 342 O HOH B 386 2.16 REMARK 500 O HOH A 397 O HOH A 398 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 314 O HOH A 392 1554 1.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 82 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP B 82 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS B 7 148.03 -174.14 REMARK 500 ASN B 61 88.49 -155.72 REMARK 500 CYS A 7 141.97 -174.83 REMARK 500 ASN A 61 89.94 -154.02 REMARK 500 ASP A 82 -163.50 -116.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 211 DISTANCE = 9.36 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 B 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 B 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 B 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 B 206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 207 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NO3 A 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 206 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GLU C 4 and NLW C 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide K1N C 101 and THR C REMARK 800 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GLU D 4 and NLW D 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide K1N D 101 and THR D REMARK 800 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5ND0 RELATED DB: PDB REMARK 900 CONTAINS THE SAME LIGAND BUT MISSING THE PROM-2 SCAFFOLD REMARK 900 RELATED ID: 5NC2 RELATED DB: PDB REMARK 900 CONTAINS THE SAME LIGAND BUT MISSING BOTH SCAFFOLDS PROM-2 AND PROM- REMARK 900 1 DBREF 6RD2 B 1 111 UNP Q8N8S7 ENAH_HUMAN 1 111 DBREF 6RD2 A 1 111 UNP Q8N8S7 ENAH_HUMAN 1 111 DBREF 6RD2 C 1 5 PDB 6RD2 6RD2 1 5 DBREF 6RD2 D 1 5 PDB 6RD2 6RD2 1 5 SEQADV 6RD2 GLY B -1 UNP Q8N8S7 EXPRESSION TAG SEQADV 6RD2 SER B 0 UNP Q8N8S7 EXPRESSION TAG SEQADV 6RD2 GLY A -1 UNP Q8N8S7 EXPRESSION TAG SEQADV 6RD2 SER A 0 UNP Q8N8S7 EXPRESSION TAG SEQRES 1 B 113 GLY SER MET SER GLU GLN SER ILE CYS GLN ALA ARG ALA SEQRES 2 B 113 ALA VAL MET VAL TYR ASP ASP ALA ASN LYS LYS TRP VAL SEQRES 3 B 113 PRO ALA GLY GLY SER THR GLY PHE SER ARG VAL HIS ILE SEQRES 4 B 113 TYR HIS HIS THR GLY ASN ASN THR PHE ARG VAL VAL GLY SEQRES 5 B 113 ARG LYS ILE GLN ASP HIS GLN VAL VAL ILE ASN CYS ALA SEQRES 6 B 113 ILE PRO LYS GLY LEU LYS TYR ASN GLN ALA THR GLN THR SEQRES 7 B 113 PHE HIS GLN TRP ARG ASP ALA ARG GLN VAL TYR GLY LEU SEQRES 8 B 113 ASN PHE GLY SER LYS GLU ASP ALA ASN VAL PHE ALA SER SEQRES 9 B 113 ALA MET MET HIS ALA LEU GLU VAL LEU SEQRES 1 A 113 GLY SER MET SER GLU GLN SER ILE CYS GLN ALA ARG ALA SEQRES 2 A 113 ALA VAL MET VAL TYR ASP ASP ALA ASN LYS LYS TRP VAL SEQRES 3 A 113 PRO ALA GLY GLY SER THR GLY PHE SER ARG VAL HIS ILE SEQRES 4 A 113 TYR HIS HIS THR GLY ASN ASN THR PHE ARG VAL VAL GLY SEQRES 5 A 113 ARG LYS ILE GLN ASP HIS GLN VAL VAL ILE ASN CYS ALA SEQRES 6 A 113 ILE PRO LYS GLY LEU LYS TYR ASN GLN ALA THR GLN THR SEQRES 7 A 113 PHE HIS GLN TRP ARG ASP ALA ARG GLN VAL TYR GLY LEU SEQRES 8 A 113 ASN PHE GLY SER LYS GLU ASP ALA ASN VAL PHE ALA SER SEQRES 9 A 113 ALA MET MET HIS ALA LEU GLU VAL LEU SEQRES 1 C 5 THR GLU ASP GLU NLW SEQRES 1 D 5 THR GLU ASP GLU NLW HET NLW C 5 22 HET NLW D 5 22 HET NO3 B 201 4 HET NO3 B 202 8 HET NO3 B 203 4 HET NO3 B 204 4 HET NO3 B 205 4 HET NO3 B 206 8 HET GOL B 207 28 HET NO3 A 201 8 HET NO3 A 202 4 HET NO3 A 203 4 HET NO3 A 204 4 HET GOL A 205 14 HET GOL A 206 28 HET K1N C 101 86 HET K1N D 101 86 HETNAM NLW L-LEUCINAMIDE HETNAM NO3 NITRATE ION HETNAM GOL GLYCEROL HETNAM K1N (3~{S},7~{R},10~{R},13~{S})-4-[(3~{S},6~{R},8~{A}~{S})- HETNAM 2 K1N 1'-[(2~{S})-2-ACETAMIDO-3-(2-CHLOROPHENYL)PROPANOYL]- HETNAM 3 K1N 5-OXIDANYLIDENE-SPIRO[1,2,3,8~{A}- HETNAM 4 K1N TETRAHYDROINDOLIZINE-6,2'-PYRROLIDINE]-3-YL]CARBONYL- HETNAM 5 K1N 2-OXIDANYLIDENE-1,4-DIAZATRICYCLO[8.3.0.0^{3, HETNAM 6 K1N 7}]TRIDEC-8-ENE-13-CARBOXYLIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NLW 2(C6 H14 N2 O) FORMUL 5 NO3 10(N O3 1-) FORMUL 11 GOL 3(C3 H8 O3) FORMUL 18 K1N 2(C35 H40 CL N5 O7) FORMUL 20 HOH *207(H2 O) HELIX 1 AA1 GLY B 27 SER B 29 5 3 HELIX 2 AA2 SER B 93 LEU B 111 1 19 HELIX 3 AA3 ASP A 18 LYS A 21 5 4 HELIX 4 AA4 GLY A 27 SER A 29 5 3 HELIX 5 AA5 THR A 41 ASN A 44 5 4 HELIX 6 AA6 SER A 93 LEU A 111 1 19 SHEET 1 AA1 5 LYS B 22 PRO B 25 0 SHEET 2 AA1 5 GLN B 4 ASP B 17 -1 N ASP B 17 O LYS B 22 SHEET 3 AA1 5 SER B 33 HIS B 40 -1 O HIS B 39 N GLN B 4 SHEET 4 AA1 5 THR B 45 LYS B 52 -1 O THR B 45 N HIS B 40 SHEET 5 AA1 5 VAL B 58 ALA B 63 -1 O CYS B 62 N VAL B 48 SHEET 1 AA2 4 LYS B 22 PRO B 25 0 SHEET 2 AA2 4 GLN B 4 ASP B 17 -1 N ASP B 17 O LYS B 22 SHEET 3 AA2 4 VAL B 86 PHE B 91 -1 O GLY B 88 N MET B 14 SHEET 4 AA2 4 PHE B 77 ARG B 81 -1 N HIS B 78 O LEU B 89 SHEET 1 AA3 5 LYS A 22 PRO A 25 0 SHEET 2 AA3 5 GLN A 4 ASP A 17 -1 N ASP A 17 O LYS A 22 SHEET 3 AA3 5 SER A 33 HIS A 40 -1 O HIS A 39 N GLN A 4 SHEET 4 AA3 5 THR A 45 LYS A 52 -1 O VAL A 49 N HIS A 36 SHEET 5 AA3 5 VAL A 58 ALA A 63 -1 O VAL A 59 N GLY A 50 SHEET 1 AA4 4 LYS A 22 PRO A 25 0 SHEET 2 AA4 4 GLN A 4 ASP A 17 -1 N ASP A 17 O LYS A 22 SHEET 3 AA4 4 VAL A 86 PHE A 91 -1 O GLY A 88 N MET A 14 SHEET 4 AA4 4 PHE A 77 ARG A 81 -1 N HIS A 78 O LEU A 89 LINK N THR C 1 CBL K1N C 101 1555 1555 1.32 LINK C GLU C 4 N NLW C 5 1555 1555 1.32 LINK N THR D 1 CBL K1N D 101 1555 1555 1.32 LINK C GLU D 4 N NLW D 5 1555 1555 1.34 SITE 1 AC1 7 ARG A 10 ARG A 34 NO3 A 201 GLN B 8 SITE 2 AC1 7 ALA B 9 ARG B 10 ARG B 34 SITE 1 AC2 5 ARG B 34 HIS B 36 HOH B 304 HOH B 307 SITE 2 AC2 5 HOH B 317 SITE 1 AC3 9 GLU A 95 THR B 30 GLY B 31 PHE B 32 SITE 2 AC3 9 LYS B 52 ILE B 53 GLN B 54 NO3 B 204 SITE 3 AC3 9 HOH B 310 SITE 1 AC4 6 SER B 29 LYS B 52 GLN B 54 ASP B 55 SITE 2 AC4 6 LYS B 69 NO3 B 203 SITE 1 AC5 9 GLN A 72 ASN A 98 ALA A 101 SER A 102 SITE 2 AC5 9 MET A 105 HOH A 301 ASN B 98 SER B 102 SITE 3 AC5 9 HOH B 301 SITE 1 AC6 4 GLN A 75 LYS B 22 THR B 74 GLN B 75 SITE 1 AC7 4 VAL B 58 VAL B 59 ASN B 61 HOH B 364 SITE 1 AC8 7 GLN A 8 ALA A 9 ARG A 10 ARG A 34 SITE 2 AC8 7 ARG B 10 ARG B 34 NO3 B 201 SITE 1 AC9 5 ARG A 34 HOH A 304 HOH A 305 HOH A 307 SITE 2 AC9 5 HOH A 359 SITE 1 AD1 9 THR A 30 GLY A 31 PHE A 32 LYS A 52 SITE 2 AD1 9 ILE A 53 GLN A 54 NO3 A 204 HOH A 318 SITE 3 AD1 9 GLU B 95 SITE 1 AD2 5 SER A 29 LYS A 52 GLN A 54 ASP A 55 SITE 2 AD2 5 NO3 A 203 SITE 1 AD3 4 GLY A 27 VAL A 58 VAL A 59 HOH A 341 SITE 1 AD4 6 ARG A 47 ASN A 61 CYS A 62 ALA A 63 SITE 2 AD4 6 TYR A 87 HOH A 322 SITE 1 AD5 12 ASN A 20 MET B 14 LYS B 22 TRP B 23 SITE 2 AD5 12 THR B 30 ASN B 90 HOH B 326 HOH B 330 SITE 3 AD5 12 THR C 1 GLU C 2 ASP C 3 K1N C 101 SITE 1 AD6 16 TYR A 16 ASP A 18 HOH A 310 TYR B 16 SITE 2 AD6 16 TRP B 23 PHE B 77 GLN B 79 ARG B 81 SITE 3 AD6 16 HOH B 324 GLU C 2 ASP C 3 GLU C 4 SITE 4 AD6 16 NLW C 5 HOH C 205 HOH C 206 HOH C 207 SITE 1 AD7 13 MET A 14 LYS A 22 TRP A 23 THR A 30 SITE 2 AD7 13 ASN A 90 HOH A 316 HOH A 335 ASN B 20 SITE 3 AD7 13 THR D 1 GLU D 2 ASP D 3 K1N D 101 SITE 4 AD7 13 HOH D 201 SITE 1 AD8 17 TYR A 16 TRP A 23 PHE A 77 GLN A 79 SITE 2 AD8 17 ARG A 81 VAL A 86 HOH A 385 TYR B 16 SITE 3 AD8 17 ASP B 18 LYS B 21 HOH B 378 GLU C 2 SITE 4 AD8 17 GLU D 2 ASP D 3 GLU D 4 NLW D 5 SITE 5 AD8 17 HOH D 202 CRYST1 148.390 44.000 34.830 90.00 102.17 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006739 0.000000 0.001453 0.00000 SCALE2 0.000000 0.022727 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029371 0.00000